Actos Bladder Cancer
The Food and Drug Administration warned in June 2011 that patients who use the type II diabetes drug Actos may face an increased risk of developing bladder cancer. The agency has advised doctors and patients to be cautious in using Actos to treat diabetes because of this increased bladder cancer risk.
The FDA’s Actos warning was based on preliminary results from a planned 10 year study of the drug. Researchers found that patients who used Actos for more than one year or who took the drug at its highest doses were more likely to develop bladder cancer than non-users. Patients who took Actos for more than 12 months were 40% more likely than non-users to develop bladder cancer.
The agency’s finding about the link between Actos and bladder cancer were confirmed by the results of a French study, which also associated the use of Actos for more than one year or at higher doses with an increased risk of the disease. Based on these findings concerning the potential dangers of Actos, health officials in France and Germany recalled Actos from sale in those countries.
The FDA has advised doctors to avoid prescribing Actos to patients with active bladder cancer and to use caution in prescribing the drug to patients with a history of the disease. Patients who are taking Actos and develop red-colored urine, pain while urinating, urgent need to urinate, back pain or pain in the abdomen should report these side effects to their doctor, as they could be symptoms of bladder cancer.
If you or a loved one took Actos and were diagnosed with bladder cancer, you may be eligible to file a lawsuit and receive compensation for your injuries. For a free legal consultation to find out if you qualify, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.